Press "Enter" to skip to content

New patent for Astrazeneca drug SYMBICORT

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug SYMBICORT

Annual Drug Patent Expirations for SYMBICORT
Annual Drug Patent Expirations for SYMBICORT

Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are ten patents protecting this drug and one Paragraph IV challenge.

SYMBICORT drug price trends.

Drug patent litigation for SYMBICORT.

The generic ingredient in SYMBICORT is budesonide; formoterol fumarate dihydrate. Three suppliers are listed for this compound. Additional details are available on the budesonide; formoterol fumarate dihydrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug SYMBICORT
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions